XML 32 R21.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 15 - Stockholders' Equity
 3 Months Ended
Dec. 31, 2018
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]
1
5
. STOCKHOLDERS’ EQUITY
 
Summary
 
The following table summarizes changes in the components of stockholders’ equity during the
three
months ended
December 31, 2017
and the
three
months ended
December 31, 2018:
 
   
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
Accumulated
   
 
 
 
   
 
 
 
  
 
 
 
  
Additional
    
 
 
 
  
Other
    
Total
  
   
Common Stock
    
Paid-in
    
Accumulated
   
Comprehensive
    
Stockholders'
  
   
Shares
    
Amount
    
Capital
    
Deficit
    
Loss
    
Equity
  
Balance at September 30, 2017
    
31,158,436
     $
322
     $
87,956,839
     $
(52,771,853
 )   $
(1,269
 )   $
35,184,039
  
                                                 
Share-based compensation expense
    
-
      
-
      
138,461
      
-
      
-
      
138,461
  
Issuance of common stock upon exercise of stock options, net
    
90,852
      
-
      
159,518
      
-
      
-
      
159,518
  
Other comprehensive loss
    
-
      
-
      
-
      
-
      
(8,031
 )    
(8,031
 )
Net income
    
-
      
-
      
-
      
(1,683,253
 )    
-
      
(1,683,253
 )
Balance at December 31, 2017
    
31,249,288
     $
322
     $
88,254,818
     $
(54,455,106
 )   $
(9,300
 )   $
33,790,734
  
 
   
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
Accumulated
   
 
 
 
   
 
 
 
  
 
 
 
  
Additional
    
 
 
 
  
Other
    
Total
  
   
Common Stock
    
Paid-in
    
Accumulated
   
Comprehensive
    
Stockholders'
  
   
Shares
    
Amount
    
Capital
    
Deficit
    
Loss
    
Equity
  
Balance at September 30, 2018
    
33,176,146
     $
332
     $
90,251,145
     $
(56,516,895
 )   $
(245,375
 )   $
33,489,207
  
                                                 
Share-based compensation expense
    
-
      
-
      
133,845
      
-
      
-
      
133,845
  
Issuance of common stock upon exercise of stock options, net
    
1,600
      
-
      
2,528
      
-
      
-
      
2,528
  
Stock buyback
    
(588,425
 )    
(6
 )    
(1,621,016
 )    
-
      
-
      
(1,621,022
 )
Other comprehensive loss
    
-
      
-
      
-
      
-
      
(54,335
 )    
(54,335
 )
Net income
    
-
      
-
      
-
      
1,045,940
      
-
      
1,045,940
  
Balance at December 31, 2018
    
32,589,321
     $
326
     $
88,766,502
     $
(55,470,955
 )   $
(299,710
 )   $
32,996,163
  
 
Share Buyback Program
 
The Board of Directors approved a share buyback program in
2015
under which the Company was authorized to repurchase up to
$4
million of its outstanding common shares. In
December 2017,
the Board of Directors extended the program through
December 31, 2018.
During the
three
months ended
December 31, 2018,
588,425
shares were repurchased for
$1,621,022.
During the
three
months ended
December 31, 2017
no
shares were repurchased. At
December 31, 2018,
all repurchased shares were retired into treasury.
 
In
December 2018,
the Board of Directors approved a new share buyback program beginning
January 1, 2019
and expiring on
December 31, 2020,
under which the Company was authorized to repurchase up to
$5
million of its outstanding common shares. The previous program expired on
December 31, 2018.
 
Dividends
 
There were
no
dividends declared in the
three
months ended
December 31, 2018
and
2017.